Abstract 548: Separation of Lipoprotein Particles Utilizing Asymmetric Flow Field-flow Fractionation and Quantitation of Apolipoprotein L1 in Human Plasma with IMER-UPLC-MS/MS

Michael L. Andrews,Zsuzsanna Kuklenyik,Yulanda M. Williamson,Kevin Bierbaum,David Schieltz,Bryan A. Parks,Christopher Toth,Michael Gardner,Lisa G. McWilliams,Anthony Lehtikoski,Jon Rees,John R. Barr

Abstract 548: Separation of Lipoprotein Particles Utilizing Asymmetric Flow Field-flow Fractionation and Quantitation of Apolipoprotein L1 in Human Plasma with IMER-UPLC-MS/MS

2018

Michael L. Andrews
Zsuzsanna Kuklenyik
Yulanda M. Williamson
Kevin Bierbaum
David Schieltz
Bryan A. Parks
Christopher Toth
Michael Gardner
Lisa G. McWilliams
Anthony Lehtikoski
Jon Rees
John R. Barr

Apolipoprotein L1 (ApoL1) is an intriguing protein and was shown to be involved in numerous diseases states such as chronic kidney disease (CKD), cardiovascular diseases(CVD), Human Immunodeficienc...

Keywords:

Biochemistry
Apolipoprotein L1
Biology
Plasma
High-performance liquid chromatography
Asymmetric flow field flow fractionation
Lipoprotein
Diabetes mellitus
human plasma
Chromatography
Kidney disease
uplc ms ms

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations